"Multi-Bagger" Portfolio Update

Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but we're watching to see if any of them could possibly bounce back with major returns - dare I say "multi-bagger" returns - in 2023. As such, I'm watching 12 microcap stocks with market capitalizations between $100M and $399M (average of $189M), which I'm calling the munKNEE "Multi-bagger" Portfolio.

Here's an update on how the various categories in the Portfolio, and their constituents, have performed year-to-date and last week.

  1. American Cannabis MSO constituents:
    • Acreage (ACRDF/ACRHF): +41.7% YTD, -11.9% last week;
    • Ascend (AAWH): +4.6% YTD, -1.4% last week;
    • Ayr (AYRWF): +11.6% YTD, +6.3% last week;
    • Columbia Care (CCHWF): -6.7% YTD, -4.1 last week;
    • Jushi (JUSHF): +1.4% YTD, +27.1% last week; and
    • Planet 13 (PLNHF): +31.9% YTD, +1.1% last week.
      • +14.9% YTD; Last week: -0.4%
  2. Canadian Cannabis LP constituents:
    • Aurora (ACB): +2.2% YTD, -14.2% last week; and
    • Organigram (OGI): +7.7% YTD, -7.7% last week.
      • +4.8% YTD; Last week: -11.2%
  3. Psychedelic Drug Stock constituents:
    • Cybin (CYBN): + 44.8% YTD, -4.5% last week;
    • Mind Medicine (MNMD): +73.9% YTD, +9.5% last week; and
    • Seelos Therapeutics (SEEL): +12.3% YTD, -13.1% last week.
      • +51.9% YTD; Last week: No Change
  4. Plant-Based Food Stock constituent:
    • Tattooed Chef (TTCF): No Change YTD, -24.8% last week.
      •  No Change YTD; Last week: -24.8%

Grand Total: +21.6% YTD; Last week: -4.4% 

The munKNEE "Multi-bagger" Portfolio continues to outperform our munKNEE "Rags-to-Riches" Portfolio, which is only up 6.2% YTD and was DOWN 7.8% last week.

Also, for the purposes of comparison with other market portfolios, we're also calling the 8 stocks in groups 1 and 2 our "Just Cannabis Multi-Bagger
. It's up 12.7% YTD.

More By This Author:

Canadian Cannabis LPs: CGC's Plunge Drags Category Down
Canopy Q3: Revenue -14%, Net Loss +15%; To Cut Jobs By ~60%
Aurora Q2 Financials: Net Revenue +25%, Net Profit -30%, Adj. EBITDA Turned Positive

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.